{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:31:29Z","timestamp":1793644289701,"version":"4.5.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"8041","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2024,12,5]]},"DOI":"10.1038\/s41586-024-08250-x","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:03:57Z","timestamp":1729699437000},"page":"162-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Long-term lineage commitment in haematopoietic stem cell gene therapy"],"prefix":"10.1038","volume":"636","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-3384","authenticated-orcid":false,"given":"Andrea","family":"Calabria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4220-2474","authenticated-orcid":false,"given":"Giulio","family":"Spinozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6366-4224","authenticated-orcid":false,"given":"Daniela","family":"Cesana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Buscaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Benedicenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5621-4803","authenticated-orcid":false,"given":"Giulia","family":"Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4626-1386","authenticated-orcid":false,"given":"Francesco","family":"Gazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3413-8414","authenticated-orcid":false,"given":"Maria Rosa","family":"Lidonnici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Scaramuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1594-5835","authenticated-orcid":false,"given":"Simona","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Canarutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Omrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"De Mattia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Dionisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Marktel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7476-4087","authenticated-orcid":false,"given":"Francesca","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3514-666X","authenticated-orcid":false,"given":"Valeria","family":"Calbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-4371","authenticated-orcid":false,"given":"Sabina","family":"Cenciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ferrua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6024-4718","authenticated-orcid":false,"given":"Bernhard","family":"Gentner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-3265","authenticated-orcid":false,"given":"Giulio","family":"Caravagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-0123","authenticated-orcid":false,"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-527X","authenticated-orcid":false,"given":"Luigi","family":"Naldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-1717","authenticated-orcid":false,"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-6067","authenticated-orcid":false,"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"8250_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","volume":"22","author":"G Ferrari","year":"2021","unstructured":"Ferrari, G., Thrasher, A. J. & Aiuti, A. Gene therapy using haematopoietic stem and progenitor cells. Nat. Rev. Genet. 22, 216\u2013234 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"8250_CR2","doi-asserted-by":"publisher","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi, A. et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341, 1233158\u20131233158 (2013).","journal-title":"Science"},{"key":"8250_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30374-9","author":"M Sessa","year":"2016","unstructured":"Sessa, M. et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial. Lancet https:\/\/doi.org\/10.1016\/s0140-6736(16)30374-9 (2016).","journal-title":"Lancet"},{"key":"8250_CR4","doi-asserted-by":"publisher","first-page":"1233151","DOI":"10.1126\/science.1233151","volume":"341","author":"A Aiuti","year":"2013","unstructured":"Aiuti, A. et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341, 1233151 (2013).","journal-title":"Science"},{"key":"8250_CR5","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/S2352-3026(19)30021-3","volume":"6","author":"F Ferrua","year":"2019","unstructured":"Ferrua, F. et al. Lentiviral haemopoietic stem\/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1\/2 clinical study. Lancet Haematol. 6, e239\u2013e253 (2019).","journal-title":"Lancet Haematol."},{"key":"8250_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","volume":"25","author":"S Marktel","year":"2019","unstructured":"Marktel, S. et al. Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ss-thalassemia. Nat. Med. 25, 234\u2013241 (2019).","journal-title":"Nat. Med."},{"key":"8250_CR7","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41409-019-0573-6","volume":"54","author":"F Tucci","year":"2019","unstructured":"Tucci, F. et al. Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy. Bone Marrow Transplant 54, 1995\u20132003 (2019).","journal-title":"Bone Marrow Transplant"},{"key":"8250_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28762-2","volume":"13","author":"F Tucci","year":"2022","unstructured":"Tucci, F., Galimberti, S., Naldini, L., Valsecchi, M. G. & Aiuti, A. A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders. Nat. Commun. 13, 1315 (2022).","journal-title":"Nat. Commun."},{"key":"8250_CR9","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler, F. et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N. Engl. J. Med. 377, 1630\u20131638 (2017).","journal-title":"N. Engl. J. Med."},{"key":"8250_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jama.2015.3253","volume":"313","author":"S Hacein-Bey Abina","year":"2015","unstructured":"Hacein-Bey Abina, S. et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA 313, 1550\u20131563 (2015).","journal-title":"JAMA"},{"key":"8250_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","volume":"371","author":"S Hacein-Bey-Abina","year":"2014","unstructured":"Hacein-Bey-Abina, S. et al. A modified \u03b3-retrovirus vector for X-linked severe combined immunodeficiency. New Engl. J. Med. 371, 1407\u20131417 (2014).","journal-title":"New Engl. J. Med."},{"key":"8250_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0735-5","author":"DB Kohn","year":"2020","unstructured":"Kohn, D. B. et al. Lentiviral gene therapy for X-linked chronic granulomatous disease. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-019-0735-5 (2020).","journal-title":"Nat. Med."},{"key":"8250_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01389-4","author":"D Cesana","year":"2021","unstructured":"Cesana, D. et al. Retrieval of vector integration sites from cell-free DNA. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-021-01389-4 (2021).","journal-title":"Nat. Med."},{"key":"8250_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/gm568","volume":"6","author":"S Firouzi","year":"2014","unstructured":"Firouzi, S. et al. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med. 6, 46\u201346 (2014).","journal-title":"Genome Med."},{"key":"8250_CR15","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41591-018-0195-3","volume":"24","author":"S Scala","year":"2018","unstructured":"Scala, S. et al. Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans. Nat. Med. 24, 1683\u20131690 (2018).","journal-title":"Nat. Med."},{"key":"8250_CR16","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1182\/blood.2019002350","volume":"135","author":"E Six","year":"2020","unstructured":"Six, E. et al. Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs. Blood 135, 1219\u20131231 (2020).","journal-title":"Blood"},{"key":"8250_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.stem.2016.04.016","volume":"19","author":"L Biasco","year":"2016","unstructured":"Biasco, L. et al. In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases. Cell Stem Cell 19, 107\u2013119 (2016).","journal-title":"Cell Stem Cell"},{"key":"8250_CR18","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1172\/JCI31666","volume":"117","author":"A Aiuti","year":"2007","unstructured":"Aiuti, A. et al. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J. Clin. Invest. 117, 2233\u20132240 (2007).","journal-title":"J. Clin. Invest."},{"key":"8250_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31344-x","volume":"13","author":"SS De Ravin","year":"2022","unstructured":"De Ravin, S. S. et al. Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency. Nat. Commun. 13, 3710 (2022).","journal-title":"Nat. Commun."},{"key":"8250_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier, N. et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326, 818\u2013823 (2009).","journal-title":"Science"},{"key":"8250_CR21","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","volume":"385","author":"B Gentner","year":"2021","unstructured":"Gentner, B. et al. Hematopoietic stem- and progenitor-cell gene therapy for Hurler syndrome. N. Engl. J. Med. 385, 1929\u20131940 (2021).","journal-title":"N. Engl. J. Med."},{"key":"8250_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","volume":"399","author":"F Fumagalli","year":"2022","unstructured":"Fumagalli, F. et al. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access. Lancet 399, 372\u2013383 (2022).","journal-title":"Lancet"},{"key":"8250_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa2109167","volume":"386","author":"S Goyal","year":"2022","unstructured":"Goyal, S. et al. Acute myeloid leukemia case after gene therapy for sickle cell disease. N. Engl. J. Med. 386, 138\u2013147 (2022).","journal-title":"N. Engl. J. Med."},{"key":"8250_CR24","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1182\/blood.2021011488","volume":"138","author":"RJ Jones","year":"2021","unstructured":"Jones, R. J. & DeBaun, M. R. Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither. Blood 138, 942\u2013947 (2021).","journal-title":"Blood"},{"key":"8250_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02636-6","author":"M Spencer Chapman","year":"2023","unstructured":"Spencer Chapman, M. et al. Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-023-02636-6 (2023).","journal-title":"Nat. Med."},{"key":"8250_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ajh.26741","volume":"98","author":"J Kanter","year":"2023","unstructured":"Kanter, J. et al. Lovo-cel gene therapy for sickle cell disease: treatment process evolution and outcomes in the initial groups of the HGB-206 study. Am. J. Hematol. 98, 11\u201322 (2023).","journal-title":"Am. J. Hematol."},{"key":"8250_CR27","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nmeth1103","volume":"4","author":"M Schmidt","year":"2007","unstructured":"Schmidt, M. et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat. Methods 4, 1051\u20131057 (2007).","journal-title":"Nat. Methods"},{"key":"8250_CR28","doi-asserted-by":"publisher","first-page":"bbac551","DOI":"10.1093\/bib\/bbac551","volume":"24","author":"G Pais","year":"2023","unstructured":"Pais, G. et al. ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications. Brief Bioinform. 24, bbac551 (2023).","journal-title":"Brief Bioinform."},{"key":"8250_CR29","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1098\/rstb.2010.0272","volume":"365","author":"A Chao","year":"2010","unstructured":"Chao, A., Chiu, C. H. & Jost, L. Phylogenetic diversity measures based on Hill numbers. Phil. Trans. R. Soc. B: Biol. Sci. 365, 3599\u20133609 (2010).","journal-title":"Phil. Trans. R. Soc. B: Biol. Sci."},{"key":"8250_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cyto.b.20008","volume":"60","author":"EG van Lochem","year":"2004","unstructured":"van Lochem, E. G. et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin. Cytom. 60, 1\u201313 (2004).","journal-title":"Cytometry B Clin. Cytom."},{"key":"8250_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41591-021-01641-x","volume":"28","author":"A Magnani","year":"2022","unstructured":"Magnani, A. et al. Long-term safety and efficacy of lentiviral hematopoietic stem\/progenitor cell gene therapy for Wiskott-Aldrich syndrome. Nat. Med. 28, 71\u201380 (2022).","journal-title":"Nat. Med."},{"key":"8250_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2023-178732","volume":"142","author":"S Radtke","year":"2023","unstructured":"Radtke, S. et al. Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation. Blood 142, 33\u201343 (2023).","journal-title":"Blood"},{"key":"8250_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa2113206","volume":"386","author":"F Locatelli","year":"2022","unstructured":"Locatelli, F. et al. Betibeglogene autotemcel gene therapy for non-beta(0)\/beta(0) genotype beta-thalassemia. N. Engl. J. Med. 386, 415\u2013427 (2022).","journal-title":"N. Engl. J. Med."},{"key":"8250_CR34","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","volume":"378","author":"AA Thompson","year":"2018","unstructured":"Thompson, A. A. et al. Gene therapy in patients with transfusion-dependent beta-thalassemia. N. Engl. J. Med. 378, 1479\u20131493 (2018).","journal-title":"N. Engl. J. Med."},{"key":"8250_CR35","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1182\/blood.V91.6.2139","volume":"91","author":"M Cazzola","year":"1998","unstructured":"Cazzola, M. et al. Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood 91, 2139\u20132145 (1998).","journal-title":"Blood"},{"key":"8250_CR36","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.stem.2015.01.017","volume":"16","author":"E Laurenti","year":"2015","unstructured":"Laurenti, E. et al. CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell 16, 302\u2013313 (2015).","journal-title":"Cell Stem Cell"},{"key":"8250_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41590-021-00925-1","volume":"22","author":"KB Kaufmann","year":"2021","unstructured":"Kaufmann, K. B. et al. A latent subset of human hematopoietic stem cells resists regenerative stress to preserve stemness. Nat. Immunol. 22, 723\u2013734 (2021).","journal-title":"Nat. Immunol."},{"key":"8250_CR38","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cell.2016.10.022","volume":"167","author":"JM Bernitz","year":"2016","unstructured":"Bernitz, J. M., Kim, H. S., MacArthur, B., Sieburg, H. & Moore, K. Hematopoietic stem cells count and remember self-renewal divisions. Cell 167, 1296\u20131309 e1210 (2016).","journal-title":"Cell"},{"key":"8250_CR39","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1002\/stem.2208","volume":"33","author":"C Glait-Santar","year":"2015","unstructured":"Glait-Santar, C. et al. Functional niche competition between normal hematopoietic stem and progenitor cells and myeloid leukemia cells. Stem Cells 33, 3635\u20133642 (2015).","journal-title":"Stem Cells"},{"key":"8250_CR40","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.3324\/haematol.2016.154740","volume":"102","author":"MR Lidonnici","year":"2017","unstructured":"Lidonnici, M. R. et al. Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone. Haematologica 102, e120\u2013e124 (2017).","journal-title":"Haematologica"},{"key":"8250_CR41","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1182\/blood-2005-09-3592","volume":"107","author":"A Larochelle","year":"2006","unstructured":"Larochelle, A. et al. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood 107, 3772\u20133778 (2006).","journal-title":"Blood"},{"key":"8250_CR42","doi-asserted-by":"publisher","first-page":"e151847","DOI":"10.1172\/jci.insight.151847","volume":"7","author":"S Felker","year":"2022","unstructured":"Felker, S. et al. Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment. JCI Insight 7, e151847 (2022).","journal-title":"JCI Insight"},{"key":"8250_CR43","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.exphem.2008.06.010","volume":"36","author":"Q Feng","year":"2008","unstructured":"Feng, Q. et al. Nonhuman primate allogeneic hematopoietic stem cell transplantation by intraosseus vs intravenous injection: engraftment, donor cell distribution, and mechanistic basis. Exp. Hematol. 36, 1556\u20131566 (2008).","journal-title":"Exp. Hematol."},{"key":"8250_CR44","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1182\/blood-2002-07-1995","volume":"101","author":"T Yahata","year":"2003","unstructured":"Yahata, T. et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD\/SCID mice bone marrow. Blood 101, 2905\u20132913 (2003).","journal-title":"Blood"},{"key":"8250_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","volume":"561","author":"H Lee-Six","year":"2018","unstructured":"Lee-Six, H. et al. Population dynamics of normal human blood inferred from somatic mutations. Nature 561, 473\u2013478 (2018).","journal-title":"Nature"},{"key":"8250_CR46","doi-asserted-by":"publisher","first-page":"e08687","DOI":"10.7554\/eLife.08687","volume":"4","author":"B Werner","year":"2015","unstructured":"Werner, B. et al. Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions. eLife 4, e08687 (2015).","journal-title":"eLife"},{"key":"8250_CR47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","volume":"606","author":"E Mitchell","year":"2022","unstructured":"Mitchell, E. et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature 606, 343\u2013350 (2022).","journal-title":"Nature"},{"key":"8250_CR48","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.omtm.2020.03.021","volume":"17","author":"JE Adair","year":"2020","unstructured":"Adair, J. E. et al. DNA barcoding in nonhuman primates reveals important limitations in retrovirus integration site analysis. Mol. Ther. Methods Clin. Dev. 17, 796\u2013809 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"8250_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.stem.2020.07.018","volume":"27","author":"W Pei","year":"2020","unstructured":"Pei, W. et al. Resolving fates and single-cell transcriptomes of hematopoietic stem cell clones by PolyloxExpress barcoding. Cell Stem Cell 27, 383\u2013395 e388 (2020).","journal-title":"Cell Stem Cell"},{"key":"8250_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.stem.2015.05.003","volume":"17","author":"EM Pietras","year":"2015","unstructured":"Pietras, E. M. et al. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell 17, 35\u201346 (2015).","journal-title":"Cell Stem Cell"},{"key":"8250_CR51","doi-asserted-by":"publisher","first-page":"e66922","DOI":"10.7554\/eLife.66922","volume":"11","author":"AS Eisele","year":"2022","unstructured":"Eisele, A. S. et al. Erythropoietin directly remodels the clonal composition of murine hematopoietic multipotent progenitor cells. eLife 11, e66922 (2022).","journal-title":"eLife"},{"key":"8250_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature12026","volume":"497","author":"N Mossadegh-Keller","year":"2013","unstructured":"Mossadegh-Keller, N. et al. M-CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 497, 239\u2013243 (2013).","journal-title":"Nature"},{"key":"8250_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.20131189","volume":"211","author":"A Grover","year":"2014","unstructured":"Grover, A. et al. Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate. J. Exp. Med. 211, 181\u2013188 (2014).","journal-title":"J. Exp. Med."},{"key":"8250_CR54","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1182\/blood-2016-05-714329","volume":"129","author":"M Endele","year":"2017","unstructured":"Endele, M. et al. CSF-1-induced Src signaling can instruct monocytic lineage choice. Blood 129, 1691\u20131701 (2017).","journal-title":"Blood"},{"key":"8250_CR55","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.3390\/ijms23095063","volume":"23","author":"G Brown","year":"2022","unstructured":"Brown, G. The social norm of hematopoietic stem cells and dysregulation in leukemia. Int. J. Mol. Sci. 23, 5063 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"8250_CR56","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ydbio.2021.03.003","volume":"475","author":"Y Ding","year":"2021","unstructured":"Ding, Y., Liu, Z. & Liu, F. Transcriptional and epigenetic control of hematopoietic stem cell fate decisions in vertebrates. Dev. Biol. 475, 156\u2013164 (2021).","journal-title":"Dev. Biol."},{"key":"8250_CR57","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41556-023-01137-5","volume":"25","author":"Y Meng","year":"2023","unstructured":"Meng, Y. et al. Epigenetic programming defines haematopoietic stem cell fate restriction. Nat. Cell Biol. 25, 812\u2013822 (2023).","journal-title":"Nat. Cell Biol."},{"key":"8250_CR58","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2011-12-380113","volume":"119","author":"H Takizawa","year":"2012","unstructured":"Takizawa, H., Boettcher, S. & Manz, M. G. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 119, 2991\u20133002 (2012).","journal-title":"Blood"},{"key":"8250_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41556-019-0444-9","volume":"22","author":"A Batsivari","year":"2020","unstructured":"Batsivari, A. et al. Dynamic responses of the haematopoietic stem cell niche to diverse stresses. Nat. Cell Biol. 22, 7\u201317 (2020).","journal-title":"Nat. Cell Biol."},{"key":"8250_CR60","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1182\/blood.2019002721","volume":"136","author":"A Aprile","year":"2020","unstructured":"Aprile, A. et al. Hematopoietic stem cell function in beta-thalassemia is impaired and is rescued by targeting the bone marrow niche. Blood 136, 610\u2013622 (2020).","journal-title":"Blood"},{"key":"8250_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-020-00734-9","volume":"13","author":"N Nanthatanti","year":"2020","unstructured":"Nanthatanti, N. et al. Leukocyte telomere length in patients with transfusion-dependent thalassemia. BMC Med. Genomics 13, 73 (2020).","journal-title":"BMC Med. Genomics"},{"key":"8250_CR62","doi-asserted-by":"publisher","first-page":"eabq3679","DOI":"10.1126\/scitranslmed.abq3679","volume":"15","author":"A Aprile","year":"2023","unstructured":"Aprile, A. et al. Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in beta-thalassemia. Sci. Transl. Med. 15, eabq3679 (2023).","journal-title":"Sci. Transl. Med."},{"key":"8250_CR63","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1172\/JCI123191","volume":"129","author":"S Crippa","year":"2019","unstructured":"Crippa, S. et al. Bone marrow stromal cells from beta-thalassemia patients have impaired hematopoietic supportive capacity. J. Clin. Invest. 129, 1566\u20131580 (2019).","journal-title":"J. Clin. Invest."},{"key":"8250_CR64","doi-asserted-by":"publisher","first-page":"101137","DOI":"10.1016\/j.blre.2023.101137","volume":"63","author":"V Gorur","year":"2024","unstructured":"Gorur, V., Kranc, K. R., Ganuza, M. & Telfer, P. Haematopoietic stem cell health in sickle cell disease and its implications for stem cell therapies and secondary haematological disorders. Blood Rev. 63, 101137 (2024).","journal-title":"Blood Rev."},{"key":"8250_CR65","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1182\/blood-2010-09-255679","volume":"117","author":"M Cavazzana-Calvo","year":"2011","unstructured":"Cavazzana-Calvo, M. et al. Is normal hematopoiesis maintained solely by long-term multipotent stem cells. Blood 117, 4420\u20134424 (2011).","journal-title":"Blood"},{"key":"8250_CR66","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12859-017-1937-9","volume":"18","author":"G Spinozzi","year":"2017","unstructured":"Spinozzi, G. et al. VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites. BMC Bioinf. 18, 520 (2017).","journal-title":"BMC Bioinf."},{"key":"8250_CR67","doi-asserted-by":"publisher","unstructured":"Berry, C. C. et al. Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/bts004 (2012).","DOI":"10.1093\/bioinformatics\/bts004"},{"key":"8250_CR68","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","volume":"117","author":"A Biffi","year":"2011","unstructured":"Biffi, A. et al. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 117, 5332\u20135339 (2011).","journal-title":"Blood"},{"key":"8250_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1890\/13-0133.1","volume":"84","author":"A Chao","year":"2014","unstructured":"Chao, A. et al. Rarefaction and extrapolation with Hill numbers: a framework for sampling and estimation in species diversity studies. Ecol. Monogr. 84, 45\u201367 (2014).","journal-title":"Ecol. Monogr."},{"key":"8250_CR70","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-0716-0301-7_11","volume":"2117","author":"G Yu","year":"2020","unstructured":"Yu, G. Gene ontology semantic similarity analysis using GOSemSim. Methods Mol. Biol. 2117, 207\u2013215 (2020).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08250-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08250-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08250-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:49:38Z","timestamp":1733395778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08250-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":70,"journal-issue":{"issue":"8041","published-print":{"date-parts":[[2024,12,5]]}},"alternative-id":["8250"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-08250-x","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"16 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The San Raffaele Telethon Institute for GT (SR-Tiget) is a joint venture between the Telethon Foundation and Ospedale San Raffaele. Lentiviral vector-based gene therapy for metachromatic leukodystrophy (MLD), developed at SR-Tiget, was licensed to Orchard Therapeutics in 2018.\u00a0Lentiviral vector-based gene therapy for Wiskott\u2013Aldrich (WAS) syndrome was developed by Fondazione Telethon.\u00a0Lentiviral vector-based gene therapy for \u03b2-thalassemia was developed at SR-Tiget.\u00a0Gene therapy for MLD is approved in the EU (Libmeldy) and in the US (Lenmeldy).\u00a0A.A. was the principal investigator of the pilot and pivotal SR-Tiget clinical trial of GT for MLD,\u00a0WAS and \u03b2-Thal. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}